Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients-Results from EORTC trial 11001

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 1, 2010, Pages 284-287

  Bendel, Peter ^a   Wittig, Andrea ^b   Basilico, Fabrizio ^c   Mauri, Pier Luigi ^c   Sauerwein, Wolfgang ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

10B NMR; BNCT; BPA; BSH; BSSB

Indexed keywords

BOROCAPTATE; BORON 10; BORONOPHENYLALANINEFRUCTOSE COMPLEX; DIMER; DRUG CARRIER; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; DISSOCIATION; DRUG TUMOR LEVEL; HEAD AND NECK CARCINOMA; HUMAN; METABOLISM; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; URINALYSIS;

ANIMALS; BOROHYDRIDES; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; FRUCTOSE; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHENYLALANINE; SULFHYDRYL COMPOUNDS; TIME FACTORS;

EID: 70349335352     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.08.018     Document Type: Article

References (15)

1. Barth R.F., Coderre J.A., Graca M., Vicente H., and Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 11 (2005) 3987-4002
2. Yamamoto T., Nakai K., and Matsumura A. Boron neutron capture therapy for glioblastoma. Cancer Lett. 262 (2008) 143-152
3. Wittig A., Michel J., Moss R.L., Stecher-Rasmussen F., Arlinghaus H.F., Bendel P., Mauri P.L., Altieri S., Hilger R., Salvadori P.A., Menichetti L., Zamenhof R., and Sauerwein W. Boron analysis and boron imaging in biological materials for boron neutron capture therapy. Crit. Rev. Oncol/Hematol. 68 (2008) 66-90
4. 11B NMR. NMR Biomed. 18 (2005) 74-82
5. 19F-BPA in a mouse melanoma model. In: Larsson B., Crawford J., and Weinreich R. (Eds). Advances in Neutron Capture Therapy Volume II, Chemistry and Biology (1997), Elsevier, Amsterdam 632-639
6. Panov V., Salomon Y., Kabalka G.W., and Bendel P. Uptake and washout of borocaptate sodium and borono-phenylalanine in cultured melanoma cells: a multi-nuclear NMR study. Radiat. Res. 154 (2000) 104-112
7. Elhanati G., Salomon Y., and Bendel P. Significant differences in the retention of the borocaptate monomer (BSH) and dimer (BSSB) in malignant cells. Cancer Lett. 172 (2001) 127-132
8. Bendel P., Margalit R., Koudinova N., and Salomon Y. Non-invasive quantitative in-vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging. Radiat. Res. 164 (2005) 680-687
9. Yoshino K., Nakajima R., Takaoka A., Mori Y., Kakihana H., Mishima Y., and Ichihashi M. Determination of released boric acid in vivo after p-boronophenylalanine administration into melanoma bearing subjects. In: Larsson B., Crawford J., and Weinreich R. (Eds). Advances in Neutron Capture Therapy Volume II, Chemistry and Biology (1997), Elsevier, Amsterdam 334-338
10. Gibson C.R., Staubus A.E., Barth R.F., Yang W., Kleinholz N.M., Jones R.B., Green-Church K., Tjarks W., and Soloway A.H. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry. Drug Metab. Dispos. 29 (2001) 1588-1598
11. Wittig A., Malago M., Collette L., Huiskamp R., Bührmann S., Nievaart V., Kaiser G.M., Jöckel K.H., Schmid K.W., Ortmann U., and Sauerwein W.A. Uptake of two (10)B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC trial 11001). Int. J. Cancer 122 (2008) 1164-1171
12. Wittig A., Collette L., Moss R., and Sauerwein W.A. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001. Appl. Radiat. Isotopes 67 (2009) S59-S62
13. 10B-L-boronophenylalanine-fructose injection. Am. J. Health Syst. Pharm. 62 (2005) 2608-2610
14. Capala J., Makar M.S., and Coderre J.A. Accumulation of boron in malignant and normal cells incubated in vitro with borono-phenylalanine, mercaptoborane, or boric acid. Radiat. Res. 146 (1996) 554-560
15. Nguyen T., Brownell G.L., Holden S.A., Kahl S., Miura M., and Teicher B.A. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations. Radiat. Res. 133 (1993) 33-40